Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wuhan Fine Medtech (WFMed) is a specialized medical device company focused on the research, development, and manufacturing of interventional cardiology and radiology products. Headquartered in Wuhan, China, the company produces a comprehensive range of vascular intervention tools, including drug-eluting stents, PTCA balloon catheters, and high-precision guidewires. WFMed is recognized for its high-quality manufacturing standards, holding ISO 13485 certification and CE marks for its primary product lines. The company serves a global market, providing both branded products and OEM/ODM manufacturing services to international partners. Its mission focuses on delivering innovative and cost-effective vascular intervention technologies to improve patient outcomes worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on WFMED.